Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery againstStaphylococcus aureusinfection

    loading  Checking for direct PDF access through Ovid


We reported an erythrocyte membrane-coated nanogel (RBC-nanogel) system with combinatorial antivirulence and responsive antibiotic delivery for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection. RBC membrane was coated onto the nanogel via a membrane vesicle templated in situ gelation process, whereas the redox-responsiveness was achieved by using a disulfide bond-based crosslinker. We demonstrated that the RBC-nanogels effectively neutralized MRSA-associated toxins in extracellular environment and the toxin neutralization in turn promoted bacterial uptake by macrophages. In intracellular reducing environment, the RBC-nanogels showed an accelerated drug release profile, which resulted in more effective bacterial inhibition. When added to the macrophages infected with intracellular MRSA bacteria, the RBC-nanogels significantly inhibited bacterial growth compared to free antibiotics and non-responsive nanogel counterparts. These results indicate the great potential of the RBC-nanogel system as a new and effective antimicrobial agent against MRSA infection.

Graphical abstract

We synthesized redox-responsive hydrogel nanoparticles cloaked with red blood cell membranes, which integrate antivirulence therapy with responsive antimicrobial delivery for effective treatment against Staphylococcus aureus infection.

Related Topics

    loading  Loading Related Articles